ORY.MC BME
Oryzon Genomics S.A.
1W: +0.0%
1M: -2.9%
3M: -7.8%
YTD: -13.1%
1Y: +2.2%
3Y: +33.2%
5Y: -15.7%
€2.73 ($3.08)
-0.02 (-0.80%)
Weekly Expected Move ±2.5%
€3
€3
€3
€3
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
📊 Key Metrics
TTM€7M
Revenue
-59.8% YoY
€-4M
Net Income
+1.0% YoY
€-11M
Free Cash Flow
+29.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-4.0%
ROA-3.0%
ROIC-1.4%
Valuation
P/E-87.6
P/B1.8
EV/EBITDA-173.4
Leverage
Debt/Equity0.07
Current Ratio1.83
Interest Cov.-0.4x
Quality Scores
Piotroski F1/9
Altman Z5.38
Beneish M0.00